<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=171401"><dc:title>OSMI-4-based PROTACs do not influence O-GlcNAc transferase and O-GlcNAcylation levels in cells</dc:title><dc:creator>Bricelj,	Aleša	(Avtor)
	</dc:creator><dc:creator>Smrdel,	Lara	(Avtor)
	</dc:creator><dc:creator>Steinebach,	Christian	(Avtor)
	</dc:creator><dc:creator>Sosič,	Izidor	(Avtor)
	</dc:creator><dc:creator>Anderluh,	Marko	(Avtor)
	</dc:creator><dc:creator>Gobec,	Martina	(Avtor)
	</dc:creator><dc:description>The O-GlcNAc transferase (OGT) inhibitors disclosed thus far are burdened with certain shortcomings. We have incorporated OSMI-4, a nanomolar OGT inhibitor, into PROTACs. The prepared chimeras failed to induce effective OGT degradation or influence O-GlcNAcylation levels in MM.1S cells.</dc:description><dc:date>2025</dc:date><dc:date>2025-08-25 13:16:26</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>171401</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>